Icon Plc
Research Icon Plc (ICLR) on Bullrun: market cap USD 13.03B, P/E 306.6. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerICLR
- ExchangeNASDAQ
- CountryIreland
- SectorHealthcare
- IndustryDiagnostics & Research
- CurrencyUSD
- Market capUSD 13.03B
- P/E306.6
- Financial periodQ2 2026
- RevenueUSD 2.06B
- Net incomeUSD 72.58M
- Free cash flowUSD 238.85M
- Gross margin23.2%
Valuation Snapshot
latest market cap is USD 13.03B; P/E is 306.6.
Peer valuation comparison
Latest P/E is 306.61x versus a Healthcare sector median of 24.46x (1153.5% above).
Latest P/E is 306.61x versus a Ireland median of 22.15x (1284.2% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 8.25B | USD 229.34M | USD 861.99M | 26.1% | 2.9 | USD 647.30M | USD 2.87B | USD 9.19B |
| FY2024 | USD 8.19B | USD 739.13M | USD 1.12B | 28.6% | 8.9 | USD 538.79M | USD 3.40B | USD 9.44B |
| FY2023 | USD 8.05B | USD 554.21M | USD 1.02B | 29.0% | 6.7 | USD 378.10M | USD 3.67B | USD 9.21B |
| FY2022 | USD 7.74B | USD 505.30M | USD 421.16M | 28.6% | 6.13 | USD 288.77M | USD 4.60B | USD 8.53B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 13.03B | 306.6 | n/a | n/a |
| 2025 | 2025-12-31 | USD 13.91B | 24.6 | n/a | n/a |
| 2024 | 2024-12-31 | USD 16.94B | 22.0 | n/a | n/a |
| 2023 | 2023-12-29 | USD 23.30B | 45.6 | n/a | n/a |
| 2022 | 2022-12-30 | USD 15.86B | 34.5 | n/a | n/a |
| 2021 | 2021-12-31 | USD 25.26B | 104.6 | n/a | n/a |
About Icon Plc
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Icon Plc's market cap?
Icon Plc's market capitalization is USD 13.03B.
What is Icon Plc's P/E ratio?
Icon Plc's price-to-earnings (P/E) ratio is 306.6.
What does Icon Plc do?
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies.